Type I Interferon in Malaria: A Balancing Act

Trends in Parasitology

Volumn 33, Issue 4, 2017, Pages 257-260

  Mooney, Jason Paul ^a   Wassmer, Samuel Crocodile ^a   Hafalla, Julius Clemence ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

IL 10; immunoregulation; Interferon; Plasmodium; Tr1; Type I interferon

Indexed keywords

INTERFERON;

CELL EXPANSION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREGULATION; MALARIA; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PLASMODIUM FALCIPARUM; REGULATORY T LYMPHOCYTE; SHORT SURVEY; ANIMAL; BIOLOGICAL MODEL; CELL PROLIFERATION; CYTOLOGY; DENDRITIC CELL; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL PROLIFERATION; DENDRITIC CELLS; HUMANS; IMMUNITY, HUMORAL; INTERFERON TYPE I; MALARIA; MODELS, BIOLOGICAL; T-LYMPHOCYTES, REGULATORY;

EID: 85009830728     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2016.12.010     Document Type: Short Survey

References (11)

1. + T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188 (2012), 1178–1190.
2. 2 Walther, M., Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog., 5, 2009, e1000364.
3. 3 McNab, F., Type I interferons in infectious disease. Nat. Rev. Immunol. 15 (2015), 87–103.
4. 4 Montes de Oca, M., Type I interferons regulate immune responses in humans with blood-stage Plasmodium falciparum infection. Cell Rep. 17 (2016), 399–412.
5. 5 Zander, R.A., Type I interferons induce T regulatory 1 responses and restrict humoral immunity during experimental malaria. PLoS Pathog., 12, 2016, e1005945.
6. 6 Sebina, I., IFNAR1-signalling obstructs ICOS-mediated humoral immunity during non-lethal blood-stage Plasmodium Infection. PLoS Pathog., 12, 2016, e1005999.
7. 7 Spaulding, E., STING-licensed macrophages prime type I IFN production by plasmacytoid dendritic cells in the bone marrow during severe Plasmodium yoelii malaria. PLoS Pathog., 12, 2016, e1005975.
8. 8 Yu, X., Cross-regulation of two type I interferon signaling pathways in plasmacytoid dendritic cells controls anti-malaria immunity and host mortality. Immunity 45 (2016), 1093–1107.
9. 9 Chen, I., “Asymptomatic” malaria: a chronic and debilitating infection that should be treated. PLoS Med., 13, 2016, e1001942.
10. 10 Liehl, P., Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection. Nat. Med. 20 (2014), 47–53.
11. 11 Olotu, A., et al. Seven-year efficacy of RTS,S/AS01 malaria vaccine among young African children. N. Engl. J. Med. 374 (2016), 2519–2529.